The Smartest Way to Check Your Heart

The non-invasive test reliably detects life-threatening narrowing of the coronary arteries (coronary artery disease), the main cause of heart attacks, and provides safety for both physician and patient.

Registration check up

The Cardio Explorer® briefly explained

Play video
The Cardio Explorer in comparison
Stress ECG
Cardio Explorer
Computed Tomography (CT)
Procedure
Physical stress
Blood collection
Radiation exposure
Sensitivity*
5/10
9/10
9.5/10
Specificity*
8.5/10
8/10
8/10
Costs
Effort
45 minutes
15 minutes
60 minutes
*Sensitivity: How many sick people are correctly identified. Specificity: How many healthy people are correctly detected.
Opinions

"We believe Cardio Explorer, Exploris Health's innovative cardiac test, will significantly improve care for patients with suspected coronary artery disease."

Dr. Thomas M. Helms

Chairman of the Board of the German Foundation for the Chronically Ill

"Thanks to artificial intelligence, we finally have a tool that can meet the high demands in primary diagnostics."

E. Schönmann, MD

Specialist FMH for General Internal Medicine

"Artificial intelligence has become an indispensable part of modern medicine. It can be used to answer complex questions, as with Cardio Explorer, and ideally to avoid unnecessary examinations. The quality of medicine is thus increased, while the burden on patients is reduced."

Prof. Dr. med. Markus Béchir

Specialist FMH for General Internal Medicine

Previous
Next

Registration Cardio Explorer® Check-Up*

Learn more

*The price depends on the service level and is determined by the medical professional.

Reimbursed via Helsana (Primeo)

Advantages for medical professionals

Highest accuracy
(AUC of 0.87)

With an Area Under The Curve (AUC) of 0.87, the Cardio Explorer has an accuracy comparable to the best imaging techniques.

No process adjustment necessary


Cardio Explorer calculates the pre-test probability required by medical guidelines (ESC 2019) with higher precision than existing methods.

Risk stratification:
Relieving the burden of care.

Cardio Explorer enables precise risk stratification of patients with suspected CHD. This conserves scarce specialist resources and treats patients efficiently.

Certification (EMA, Swissmedic)



The Cardio Explorer is approved in Switzerland and all EU countries.

Broad validation in high and low prevalence populations.

Cardio Explorer has been validated in three clinical trials with over 2,000 patients, in high and low prevalence populations, and showed tremendously high accuracy in all studies (AUC of 0.87). The broad validation is a prerequisite for use in primary diagnostics and prevention.

Personalized medicine



CHD reflects a system-wide and highly complex pathophysiology that requires a comprehensive combinatorial assessment of all risk factors. Artificial intelligence (AI) allows efficient and personalized assessment.

From more than 100 factors, the 32 relevant factors were identified via an evolutionary learning process:

Medical history

Age, years
45
Gender
Man
Size, cm
182
Weight, kg
75.5
Chest pain
no
Nicotine consumption (NK)
yes

Medication

Diabetes
no
Cholesterol-lowering drugs (statin)
no
Platelet Inhibitors
no
RAS inhibitors
no
Ca antagonist
no
Beta blocker
no
Diuretics
no
Organic nitrates
no

Findings

Blood pressure syst., mm HG
129
But pressure diast., mm HG
83
pathological Q-spike compatible with expired infarct
no

Lipids

Cholesterol (total), mmol/L
4.6
HDL, mmol/L
2
LDL, mmol/L
2.5

Diabetes

Glucose (fasting), mmol/L
5.8

Proteins

Protein (total), g/L
73
Albumin, g/L
49.4

Metabolites

Bilirubin (total), μmol/L
10.8
Urea, mmol/L
7
Uric acid, μmol/L
293

Hematology

Leukocytes, G/L
4.6
MCHC, g/L
336

Enzymes

Pancreatic Amylase, U/L
22
Alkaline phosphatase, U/L
102
hs Troponin T, ng/L
3
ALAT, U/L
27

The result is available immediately after entering all factors:

No further clarification
Stenosis risk <5%
Non-invasive clarification recommended
Stenosis risk ~20%
Non-invasive clarification recommended
Stenosis risk ~50%
Non-invasive workup strongly recommended, consider invasive workup
Stenosis risk >75%
Cardio Explorer Web Portal

The Cardio Explorer® can be used without additional infrastructure.

Price per application
Secure web solution
High precision
(AUC 0.87)
No device required
Easy handling
Patient data are protected
Without software installation
No special factors required
Consultation appointment for service providers

Registration Cardio Explorer® Check-Up*

Find test center
Reimbursed via Helsana (Primeo) 
*The price depends on the service level and is determined by the medical professional.
Publications

Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort.

PDF
download

A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine.

PDF
download

A new memetic pattern based algorithm to diagnose/exclude coronary artery disease.

PDF
download